Clinical Study to Investigate the Safety and Pharmacokinetics of SK3530 Tablet in Renal Impaired Male Patients (SK3530_RI_I)
This study has been completed.
Asan Medical Center
First Posted: November 2, 2010
Last Update Posted: January 15, 2015
SK Chemicals Co.,Ltd.
Information provided by (Responsible Party):
Kyun-Seop Bae, Asan Medical Center